Good News, Bad News On Medication Adherence: Problem Understood, Now How To Fix Human Behavior?
The Centers for Medicare and Medicaid Services’ long awaited final rules on Accountable Care Organizations, issued on Oct. 20, include encouraging incentives for medication adherence. That’s good news for the industry, but it also throws a spotlight on the imperfect state of medication adherence methodologies.
You may also be interested in...
Driving Rx Adherence In Value-Based Insurance Design Needs More Than Lower Copays – Harvard Researcher
Value-based insurance design offers the promise of offering better quality care and helping to reduce costs, but getting there will require more than trying to influence behavior by reducing copayments, Harvard’s Choudhry said in a recent webinar.
A recent article funded by the National Pharmaceutical Council asserts that the success of value-based health care delivery models such as accountable care organizations will require viewing pharmaceuticals as a tool that can reduce total costs and improve quality, rather than a siloed expense.
The HHS Office of the Surgeon General issues a request for information regarding the non-adherence of prescription medication. However, it is unclear how it plans to use the information once it is collected.